関連する実験動画
Updated: Jan 8, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
免疫細胞へのニューロンの信号を遮断することで,ストレプトコック感染を治療する
Felipe A Pinho-Ribeiro1, Buket Baddal2, Rianne Haarsma1
1Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA.
Cell
|May 15, 2018
まとめ
ストレプトコッカス・ピオゲネスは 痛みの信号を使って 免疫防御を抑制し,死滅性ファシイティスの生存を助ける. この神経免疫の 交信を遮断することは 侵襲的な細菌感染に対する 新しい治療戦略を提供します
科学分野:
- 神経科学
- 免疫学
- 微生物学
背景:
- 神経系,免疫系,微生物系が バリア組織で相互作用します
- 骨髄膜炎は不釣り合いの痛みを表しており 神経機構の役割を示唆しています
- ストレプトコッカス・ピオゲネスは死滅性ファシイティスの主要な原因です.
研究 の 目的:
- 免疫反応を回避するために 神経系を操作する方法を調べる
- S. pyogenes 感染症の病原性における痛み信号の役割を調査する.
- 感染中の神経免疫通信を理解することによって,潜在的な治療標的を特定する.
主な方法:
- S.ピオゲネスと神経受容体の相互作用を研究した.
- 疼痛経路の活性化におけるストレプトリシンS (SLS) の役割を分析した.
- 免疫細胞機能に対する神経ペプチドカルシトニン遺伝子関連ペプチド (CGRP) の影響を評価した.
- マウスモデルでボトリン神経毒素AとCGRPの抗作用を評価した.
主要な成果:
- S. pyogenesはSLSを分泌し,神経受容体を直接活性化し,痛みを引き起こします.
- 活性化されたノシセプターは中性粒子の増殖と細菌の殺戮を阻害するCGRPを放出します.
- ボトリヌム神経毒素AまたはCGRP抗体による神経経路の標的化は,S. pyogenes感染を予防し,治療しました.
- これらの介入によって 宿主防御のニューロン媒介抑制が阻害された.
結論:
- S. pyogenesは 免疫反応を抑制し 生存を促進するために 痛みの信号をハイジャックします
- 侵襲性細菌感染症の治療戦略として 有望なものです
- 末神経系を標的にすると 末筋炎のような重症感染症を 治療する新しい方法が生まれます
関連する概念動画
01:27Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
01:29Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
01:29Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
01:27Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K